Clinical Trial Update: Oscillation and Lung Expansion (OLE) Therapy for Treatment of Neuromuscular Disease (NMD) Patients [NA]

View source ↗

Summary

The trial evaluating Oscillation and Lung Expansion (OLE) Therapy for neuromuscular diseases was terminated, with results posted on 2025-07-31.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromuscular Diseases

Drugs mentioned

• Oscillation and Lung Expansion (OLE) Therapy

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Neuromuscular Diseases | NA | Status: TERMINATED | Results posted: 2025-07-31